Vaxess Technologies Closes Final Tranche of $8.2 Million Series A and Appoints Dr. Purnanand Sarma to the Board
CAMBRIDGE, Mass. -- Vaxess Technologies, a biotechnology company redefining drug delivery with the silk-powered MIMIX smart release patch, today announced it has closed the final tranche of an $8.2 million Series A round. Led by The Engine, the venture capital firm launched by...
Vaxess and GC Pharma to Collaborate on Development of of Highly Effective Influenza Vaccine Smart Release Patch
CAMBRIDGE, Mass. & SEOUL, South Korea--(BUSINESS WIRE)--GC Pharma, a leading manufacturer of influenza vaccines with a global reach, and Vaxess, an innovative biotechnology company developing the MIMIX smart release patch, have partnered to commercialize a highly effective, pa...
VAXESS TECHNOLOGIES TO PRESENT AT BIOTECH SHOWCASE™ 2020 IN SAN FRANCISCO
CAMBRIDGE, Mass. January 10, 2020 – Vaxess Technologies, an innovative biotechnology company developing a pipeline of therapeutics and vaccines on the MIMIX™ smart release system, announced that it will present at the Biotech Showcase™ 2020, on Wednesday, January 15 at 10:00AM...